Several type II Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 RNA-guided nucleases are commonly used for genome engineering. Their relatively large size and requirements for specific protospacer adjacent motif (PAM) sequences flanking their targets prompt continuous searches for additional more compact Cas9 enzymes with new PAM specificities. Here, we present SuCas9, a compact nuclease from Streptococcus uberis, a bacterium inhabiting the mammary glands of dairy cattle. SuCas9 recognizes a novel 5′-NNAAA-3′ PAM, efficiently cleaves DNA in vitro, and is active in human cells. SuCas9 thus expands the available genome editing toolset and may find biotechnological and medicinal applications in the future.
Get full access to this article
View all access options for this article.
References
1.
JansenR, EmbdenJD, GaastraW, et al.Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol, 2002; 43(6):1565–1575; doi: 10.1046/j.1365-2958.2002.02839.x
2.
BarrangouR, FremauxC, DeveauH, et al.CRISPR provides acquired resistance against viruses in prokaryotes. Science, 2007; 315(5819):1709−1712; doi: 10.1126/science.1138140
3.
MarraffiniLA, SontheimerEJ. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science, 2008; 322(5909):1843–1845; doi: 10.1126/science.1165771
4.
GarneauJE, DupuisMÈ, VillionM, et al.CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 2010; 468(7320):67–71; doi: 10.1038/nature09523
5.
MakarovaKS, WolfYI, IranzoJ, et al.Evolutionary classification of CRISPR–Cas systems: A burst of class 2 and derived variants. Nat Rev Microbiol, 2020; 18(2):67–83; doi: 10.1038/s41579-019-0299-x
6.
DoudnaJA, CharpentierE. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science, 2014; 346(6213):1258096; doi: 10.1126/science.1258096
7.
MaliP, YangL, EsveltKM, et al.RNA-guided human genome engineering via Cas9. Science, 2013; 339(6121):823–826; doi: 10.1126/science.1232033
8.
CongL, RanFA, CoxD, et al.Multiplex genome engineering using CRISPR/Cas systems. Science, 2013; 339(6121):819–823; doi: 10.1126/science.1231143
9.
JinekM, EastA, ChengA, et al.RNA-programmed genome editing in human cells. Elife, 2013; 2:e00471; doi: 10.7554/eLife.00471
10.
HwangWY, FuY, ReyonD, et al.Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol, 2013; 31(3):227–229; doi: 10.1038/nbt.2501
11.
FonfaraI, Le RhunA, ChylinskiK, et al.Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res, 2014; 42(4):2577–2590; doi: 10.1093/nar/gkt1074
12.
RanFA, CongL, YanWX, et al.In vivo genome editing using Staphylococcus aureus Cas9. Nature, 2015; 520(7546):186–191; doi: 10.1038/nature14299
13.
ShahSA, ErdmannS, MojicaFJM, et al.Protospacer recognition motifs: Mixed identities and functional diversity. RNA Biol, 2013; 10(5):891–899; doi: 10.4161/rna.23764
14.
EsveltKM, MaliP, BraffJL, et al.Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods, 2013; 10(11):1116–1121; doi: 10.1038/nmeth.2681
15.
HarringtonLB, Paez-EspinoD, StaahlBT, et al.A thermostable Cas9 with increased lifetime in human plasma. Nat Commun, 2017; 8(1):1424; doi: 10.1038/s41467-017-01408-4
16.
FedorovaI, ArsenievA, SelkovaP, et al.DNA targeting by Clostridium cellulolyticum CRISPR-Cas9 type II-C system. Nucleic Acids Res, 2020; 48(4):2026–2034; doi: 10.1093/nar/gkz1225
17.
FedorovaI, VasilevaA, SelkovaP, et al.PpCas9 from Pasteurella pneumotropica — a compact type II-C Cas9 ortholog active in human cells. Nucleic Acids Res, 2020; 48(21):12297–12309; doi: 10.1093/nar/gkaa998
18.
Aliaga GoltsmanDS, AlexanderLM, LinJL, et al.Compact Cas9d and HEARO enzymes for genome editing discovered from uncultivated microbes. Nat Commun, 2022; 13(1):7602; doi: 10.1038/s41467-022-35257-7
19.
VasilevaA, SelkovaP, ArsenievA, et al.Characterization of CoCas9 nuclease from Capnocytophaga ochracea. RNA Biol, 2023; 20(1):750–759; doi: 10.1080/15476286.2023.2256578
20.
ButterfieldGL, RohmD, RobertsA, et al.Characterization of diverse Cas9 orthologs for genome and epigenome editing. Proc Natl Acad Sci U S A, 2025; 122(11):e2417674122; doi: 10.1073/pnas.2417674122
21.
WangK, WangJ, YangX, et al.Structural insights into Type II-D Cas9 and its robust cleavage activity. Nat Commun, 2025; 16(1):7396; doi: 10.1038/s41467-025-62128-8
22.
KäppeliN, MorachM, ZurfluhK, et al.Sequence types and antimicrobial resistance profiles of Streptococcus uberis isolated from bovine mastitis. Front Vet Sci, 2019; 6:234; doi: 10.3389/fvets.2019.00234
23.
LaemmliUK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970; 227(5259):680–685; doi: 10.1038/227680a0
24.
LiH, DurbinR. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics, 2010; 26(5):589–595; doi: 10.1093/bioinformatics/btp698
25.
CrooksGE, HonG, ChandoniaJM, et al.WebLogo: A sequence logo generator. Genome Res, 2004; 14(6):1188–1190; doi: 10.1101/gr.849004
26.
LeenayRT, MaksimchukKR, SlotkowskiRA, et al.Identifying and visualizing functional PAM diversity across CRISPR-Cas systems. Mol Cell, 2016; 62(1):137–147; doi: 10.1016/j.molcel.2016.02.031
27.
MaxwellCS, JacobsenT, MarshallR, et al.A detailed cell-free transcription-translation-based assay to decipher CRISPR protospacer-adjacent motifs. Methods, 2018; 143:48–57; doi: 10.1016/j.ymeth.2018.02.016
28.
BiswasA, GagnonJN, BrounsSJ, et al.CRISPRTarget: Bioinformatic prediction and analysis of crRNA targets. RNA Biol, 2013; 10(5):817–827; doi: 10.4161/rna.24046
29.
ClementK, ReesH, CanverMC, et al.CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat Biotechnol, 2019; 37(3):224–226; doi: 10.1038/s41587-019-0032-3
30.
CradickTJ, QiuP, LeeCM, et al.COSMID: A Web-based tool for identifying and validating CRISPR/Cas Off-target sites. Mol Ther Nucleic Acids, 2014; 3(12):e214; doi: 10.1038/mtna.2014.64
MaliP, AachJ, StrangesPB, et al.CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol, 2013; 31(9):833–838; doi: 10.1038/nbt.2675
33.
GasiunasG, BarrangouR, HorvathP, et al.Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A, 2012; 109(39):E2579–E2586; doi: 10.1073/pnas.1208507109
34.
KimE, KooT, ParkSW, et al.In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nat Commun, 2017; 8:14500; doi: 10.1038/ncomms14500
35.
KimD, BaeS, ParkJ, et al.Digenome-seq: Genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat Methods, 2015; 12(3):237–243, 1 p following 243; doi: 10.1038/nmeth.3284
36.
LiangSQ, LiuP, SmithJL, et al.Genome-wide detection of CRISPR editing in vivo using GUIDE-tag. Nat Commun, 2022; 13(1):437; doi: 10.1038/s41467-022-28135-9
37.
CrosettoN, MitraA, SilvaMJ, et al.Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nat Methods, 2013; 10(4):361–365; doi: 10.1038/nmeth.2408
38.
YanWX, MirzazadehR, GarneroneS, et al.BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks. Nat Commun, 2017; 8:15058; doi: 10.1038/ncomms15058
39.
LauCH, SuhY. In vivo genome editing in animals using AAV-CRISPR system: Applications to translational research of human disease. F1000Res, 2017; 6:2153; doi: 10.12688/f1000research.11243.1
40.
ColliasD, BeiselCL. CRISPR technologies and the search for the PAM-free nuclease. Nat Commun, 2021; 12(1):555; doi: 10.1038/s41467-020-20633-y
41.
HuangTP, HeinsZJ, MillerSM, et al.High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMs. Nat Biotechnol, 2023; 41(1):96–107; doi: 10.1038/s41587-022-01410-2
42.
ZhaoL, KosekiSRT, SilversteinRA, et al.PAM-flexible genome editing with an engineered chimeric Cas9. Nat Commun, 2023; 14(1):6175; doi: 10.1038/s41467-023-41829-y
43.
MahJK. Current and emerging treatment strategies for Duchenne muscular dystrophy. Neuropsychiatr Dis Treat, 2016; 12:1795–1807; doi: 10.2147/NDT.S93873
44.
GasiunasG, YoungJK, KarvelisT, et al.A catalogue of biochemically diverse CRISPR-Cas9 orthologs. Nat Commun, 2020; 11(1):5512; doi: 10.1038/s41467-020-19344-1
45.
WeiJ, HouL, LiuJ, et al.Closely related type II-C Cas9 orthologs recognize diverse PAMs. Elife, 2022; 11:e77825; doi: 10.7554/eLife.77825
46.
KonstantakosV, NentidisA, KritharaA, et al.CRISPR-Cas9 gRNA efficiency prediction: An overview of predictive tools and the role of deep learning. Nucleic Acids Res, 2022; 50(7):3616–3637; doi: 10.1093/nar/gkac192
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
